The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases (Q34985803)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases |
scientific article |
Statements
1 reference
The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases (English)
1 reference
Dulce Soler
1 reference
Tobias Chapman
1 reference
Li-Li Yang
1 reference
Tim Wyant
1 reference
Robert Egan
1 reference
Eric R Fedyk
1 reference
1 reference
Identifiers
1 reference